Why the study?
Do calcium channel blockers possess immunosuppressive properties in solid organ transplant recipients?
Do calcium channel blockers possess immunosuppressive properties in solid organ transplant recipients?
Calcium channel blockers may offer additional immunosuppressive benefits for solid organ transplant recipients beyond their cardiovascular effects.
Answers are grounded in this paper and cite their sources.
Does not support practice change in transplant recipients; leaves open whether calcium antagonists confer meaningful immunosuppression.
Calcium channel blockers are extensively used for their beneficial effects on the cardiovascular system. Solid organ transplant recipients commonly have cardiovascular disease and are often treated with these agents. Research demonstrates that calcium antagonists may have beneficial effects in this population that are independent of their effects on the cardiovascular system. Indeed, both in vitro and in vivo studies suggested that they may possess immunosuppressive properties. Their actions at the cellular level in both the afferent and efferent arms of the immune system indicate that alone, as well as in combination with cyclosporine, these agents possess immunosuppressive properties that may potentially benefit the transplant population.
No takes yet. Share an insight, caveat, or question.
Chitwood et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: